View the poster >
Presented at ELRIG 2018
View the poster >
View the poster >
View the poster >
Our team present posters at drug discovery and life science events around the world
resources
Medicines Discovery Catapult 2023/2...
Annual Report and Consolidated Financial Statement for the Year Ended 31 March 2024
resources
Mass Spectrometry Imaging at MDC
Mass Spectrometry Imaging (MSI) enables the analysis of molecular species directly from a tissue sample or any other biological surface.
resources
MDC Connects 2024 5 of 5 Commercial...
Commercialising your Innovation. The final webinar is about commercialising your innovation. Looking at options for…
resources
MDC Connects 2024 4 of 5 Protecting...
Protecting intellectual property is the title of week four. Identify the novelty, defining IP strategy…
resources
MDC Connects 2024 3 of 5 Building t...
Each year, Medicines Discovery Catapult (MDC) aims to connect the community by running a short…
resources
MDC Connects 2024 2 of 5 Securing F...
2 Securing Funds | Tuesday 20 February Week two was a talk on securing funding. Here, we…
resources
MDC Connects 2024 1 of 5 UK Life Sc...
Webinar one UK Life Sciences – the Future is Bright; creating a richer national R&D…
resources
Vascular Disease is a Major Cause o...
Vascular dementia (VaD) is the second most common form of dementia after Alzheimer’s Disease and its prevalence increases with age.
resources
Preparation, Characterisation and i...
MDC is developing new ways to characterise the physical properties of nanoparticles using single molecule localisation microscopy.
resources
Consensus Workshop | Medici...
Guiding Principles for ALS Drug Discovery and Development SUMMARY Since 2020, three UK-based organisations, Medicines…
resources
Michael Eyres, Joseph A. Be...
A defining pathological feature of human lung fibrosis is localized tissue heterogeneity, which challenges the…
resources
MDC Connects: A Guide to Complex Me...
MDC Connects was a series of weekly webinars which ran in 2021, a guide to…
resources
The Role of Collaboration in Accele...
Workshop A: 25 May 2021, organised by the Hearing Medicines Discovery Syndicate. Event run and…
resources
Our CSO, Prof. Peter Simpso...
A new wave of medicines has emerged in recent years, to supplement the established small…
resources
Shaping the UK into an epic...
Complex medicines will become as important as traditional small molecule drugs in the coming years,…
resources
MDC Connects 2021: A Guide ...
The medicines industry is in a period of change. While small molecule therapeutics still make…
resources
MDC Connects 2021: A Guide ...
The medicines industry is in a period of change. While small molecule therapeutics still make…
resources
MDC Connects 2021: A Guide ...
The medicines industry is in a period of change. While small molecule therapeutics still make…
resources
MDC Connects 2021: A Guide ...
The medicines industry is in a period of change. While small molecule therapeutics still make…
resources
MDC Connects 2021: A Guide ...
The medicines industry is in a period of change. While small molecule therapeutics still make…
resources
MDC Connects 2021: A Guide ...
The medicines industry is in a period of change. While small molecule therapeutics still make…
resources
Identifying Technologies Re...
In a quest to address novel and previously intractable targets, drug discovery is undergoing a…
resources
MDC Connects: A Guide to Drug Disco...
26 experts from MDC and our partners give their views on the latest developments in…
resources
The Emerging Hearing Medicines Land...
A monthly webinar series developed by the Hearing Medicines Discovery Syndicate, exploring hearing drug discovery…
resources
The Emerging Hearing Medicines Land...
A monthly webinar series developed by the Hearing Medicines Discovery Syndicate, exploring hearing drug discovery…
resources
The Emerging Hearing Medicines Land...
A monthly webinar series developed by the Hearing Medicines Discovery Syndicate, exploring hearing drug discovery…
resources
The Emerging Hearing Medicines Land...
A monthly webinar series developed by the Hearing Medicines Discovery Syndicate, exploring hearing drug discovery…
resources
Find out what data is avail...
We have produced a series of Data Access Guides for a number of the major…
resources
Enhancing collaboration in ...
Now more than ever, the need for establishing connections and closer collaboration is a priority…
resources
Recommendations for improvi...
About 1 million patients have consented to their samples being used specifically in research studies. There…
resources
Aiding decision making from...
In this webinar, Gayle Marshall, Lead Scientist for Biomarkers, covers why drugs fail in the…
resources
Improving lives by enabling...
This report explores the use of health data and the barriers faced by the UK life sciences industry. It highlights the tangible steps being taken by UK stakeholders…
resources
An overview of scope, eligi...
In this webinar Alessandra Gaeta, Programme Director, Syndicates, talks through the Psychiatry Consortium first call…
resources
Accelerate disease understa...
Imaging allows a non-invasive assessment of biochemical and biological processes in a living subject. Monitoring,…
resources
New insights into the UK's ...
The 2019 edition of the State of the Discovery Nation report by the Medicines Discovery…
resources
Key insights from the 2019 ...
In association with the BioIndustry Association (BIA), we have conducted our second review of the…
resources
Find out what data is avail...
We have produced a series of Data Access Guides for a number of the major…
resources
Find out what data is avail...
We have produced a series of Data Access Guides for a number of the major…
resources
Find out what data is avail...
We have produced a series of Data Access Guides for a number of the major…
resources
Find out what data is avail...
We have produced a series of Data Access Guides for a number of the major…
resources
Find out what data is avail...
We have produced a series of Data Access Guides for a number of the major…
resources
A report by the Medicines D...
The Medicines Discovery Catapult and BioIndustry Association call on the R&D community to address five…